Valeant Continues Buying Spree With $2.6B Acquisition Of Medicis
This article was originally published in The Pink Sheet Daily
Executive Summary
The specialty pharma adds to its dermatology portfolio with a proposed acquisition of Scottsdale, Ariz.-based Medicis.
You may also be interested in...
Valeant’s Pearson Is Out, As Hunt Begins For A CEO To Right The Wrongs
Valeant has begun the search for a new CEO, who will be charged with turning around the troubled company and likely divesting some assets. The company also calls out former CFO Howard Schiller for “improper conduct.”
Nestle Grows Skin Care Footprint, Valeant Gains Antitrust Cover In Derma Deal
Swiss food and beverage firm Nestle grows its stake in North American skin care with its pending $1.4 billion acquisition from Valeant of five aesthetic dermatology brands, demonstrating its commitment to health and wellness, analysts say. Valeant resolves potential antitrust obstacles to its proposed Allergan acquisition.
Nestle Grows Skin Care Footprint, Valeant Gains Antitrust Cover In Derma Deal
Swiss food and beverage firm Nestle grows its stake in North American skin care with its pending $1.4 billion acquisition from Valeant of five aesthetic dermatology brands, demonstrating its commitment to health and wellness, analysts say. Valeant resolves potential antitrust obstacles to its proposed Allergan acquisition.